Signal2026-07-21
ClinicalTrials.gov

[PHASE1] Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

Part of

Emerging Cancer Biomarker Techniques

Open primary sourceSee the whole picture